首页> 外国专利> METHOD FOR IN VITRO REPROGRAMMING OF FIBROBLASTS INTO SERTOLI CELLS AND APPLICATION THEREOF

METHOD FOR IN VITRO REPROGRAMMING OF FIBROBLASTS INTO SERTOLI CELLS AND APPLICATION THEREOF

机译:成纤维细胞中的体外重新编程的方法及其应用

摘要

Disclosed is a method for in vitro reprogramming of fibroblasts into Sertoli cells and an application thereof. The method includes the following steps: introducing a fluorescent protein reporter system specifically expressed in the Sertoli cells into the fibroblasts; followed by introducing a substance that increases the expression level and/or activity of the NR5A1 protein; adding G418 and culturing for 3-7 d; discarding the liquid phase, adding a medium for culturing fibroblasts and continuing culturing for 3-7 d; and isolating the Sertoli cells from the culture system. Experiments showed that cells prepared by the method fully acquire the characteristics of Sertoli cells, such as attracting endothelial cells, forming lipid droplets, interacting with germ cells, inhibiting lymphocyte growth and interleukin production and having immune privilege. The disclosure has application value in the fields of infertility treatment, allogeneic transplantation, and cell therapy.
机译:公开了一种用于将成纤维细胞进行体外重编程的方法及其应用。该方法包括以下步骤:将特异性在Sertoli细胞中特异性表达的荧光蛋白报告系统引入成纤维细胞中;然后引入增加NR5A1蛋白的表达水平和/或活性的物质;添加G418并培养3-7天;丢弃液相,加入培养成纤维细胞并继续培养3-7d的培养基;并从培养系统中分离血清细胞。实验表明,通过该方法制备的细胞充分地获取了Sertoli细胞的特征,例如吸引内皮细胞,形成脂液滴,与生殖细胞相互作用,抑制淋巴细胞生长和白细胞介素产生并具有免疫特征。本公开内容具有不孕症治疗,同种异体移植和细胞疗法领域的应用价值。

著录项

  • 公开/公告号EP3805375A1

    专利类型

  • 公开/公告日2021-04-14

    原文格式PDF

  • 申请/专利权人 TSINGHUA UNIVERSITY;EVERLIFE BIOMED CO. LTD.;

    申请/专利号EP20180925596

  • 发明设计人 KEE KEHKOOI;LIANG JIANLIN;

    申请日2018-07-03

  • 分类号C12N5/10;C12N15/867;C12N5/071;C12N15/65;

  • 国家 EP

  • 入库时间 2022-08-24 18:12:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号